Israel released 200 Palestinian prisoners, 120 of them serving life sentences, from its jails as part of a ceasefire deal.
Pfizer Inc. today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and mFOLFOX6 (fluorouracil, ...